iShares 3 7 Year Treasury Bond ETF vs Marsh & McLennan Companies, Inc. — how do they compare? iShares 3 7 Year Treasury Bond ETF trades at $116.37, while Marsh & McLennan Companies, Inc. trades at $176.24 (market cap $86.66B). The key difference: Marsh & McLennan Companies, Inc. pays a 2.18% dividend while iShares 3 7 Year Treasury Bond ETF pays none, and Marsh & McLennan Companies, Inc. is trading nearer its 52-week high, iShares 3 7 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| IEI | MRSH | |
|---|---|---|
Sector | Fixed Income | Financials |
52-Week High | $120.72 | $211.21 |
52-Week Low | $116.45 | $157.32 |
Market Cap | — | $86.66B |
Enterprise Value | — | $107.50B |
Dividend Yield | — | 2.18% |
Signals from Pluang's Aura AI — not financial advice
IEI (iShares 3-7 Year Treasury Bond ETF) trades at $116.76, down 0.19% with a bearish technical signal from moving averages. The ETF focuses on intermediate-term U.S. Treasury bonds, offering lower volatility compared to corporate bond alternatives. Recent news highlights institutional selling by AlTi Global Inc. and competitive pressure from Vanguard's lower-cost bond ETFs.
The outlook remains cautious amid Federal Reserve uncertainty and rising inflation concerns. While Treasury ETFs provide safety during market stress, IEI faces headwinds from potential rate hikes and stronger-yielding alternatives. Key risks include interest rate sensitivity and investor preference for higher-yield bond options in the current environment.
Marsh (MRSH) trades at $181.59, down 0.32% on the day, with a bullish technical signal from moving averages and support at $180. The company reported strong Q2 2026 earnings, beating estimates with $2.96 EPS versus $2.88 expected, driven by 6% revenue growth to $7.4 billion. Fundamentals show robust profitability with a 14.26% net margin and 27.42% ROE, while valuation ratios like P/E of 22.77 and P/S of 3.26 reflect premium pricing. Recent news highlights a 10% dividend increase to $0.99 per share, payable in August 2026.
The outlook for MRSH is positive, supported by consistent earnings beats and strategic AI investments, but risks include rising operating expenses and softer insurance pricing. Analysts maintain a consensus price target of $203.75, implying 12% upside, with 11 buy ratings outweighing 1 sell. Investors should monitor expense management and organic growth sustainability amid competitive pressures.
Trailing returns across standard periods
Latest headlines on both assets
IEI tracks the ICE U.S. Treasury 3-7 Year Bond Index, offering exposure to intermediate-term government debt. It serves as a conservative middle ground in the Treasury yield curve, providing higher yields than short-term bills with less volatility than long-term bonds.
Read more on IEI →Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →